2021

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. (Cancer Res, May 2021)

Phyllis S Y Chong # 1, Jing Yuan Chooi # 2, Julia S L Lim 2 3, Sabrina Hui Min Toh 3, Tuan Zea Tan 3, Wee-Joo Chng 1 3 4 Affiliations 1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. …

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. (Cancer Res, May 2021) Read More »

Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer

Development of novel Camsirubicin analog expands Monopar’s therapeutic pipeline WILMETTE, Ill., June 03, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing …

Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer Read More »

Extracellular Vesicles, the Cornerstone of Next-Generation Cancer Diagnosis? (Semin Cancer Biol, May 2021)

Jiayi Weng 1, Xiaoqiang Xiang 2, Lingwen Ding 3, Andrea Li-Ann Wong 4, Qi Zeng 5, Gautam Sethi 6, Lingzhi Wang 7, Soo Chin Lee 8, Boon Cher Goh 9 Affiliations 1Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore; Department of Medicine, Yong …

Extracellular Vesicles, the Cornerstone of Next-Generation Cancer Diagnosis? (Semin Cancer Biol, May 2021) Read More »

Targeting RNA Editing of Antizyme Inhibitor 1: a Potential Oligonucleotide-Based Antisense Therapy for Cancer (Mol Ther, May 2021)

Daryl Jin Tai Tay 1, Yangyang Song 1, Boya Peng 2, Tan Boon Toh 3, Lissa Hooi 1, Desiree-Faye Kaixin Toh 4, HuiQi Hong 5, Sze Jing Tang 1, Jian Han 1, Wei Liang Gan 1, Tim Hon Man Chan 1, Manchugondanahalli S Krishna 4, Kiran M Patil 4, Manikantha Maraswami 4, Teck Peng Loh 4, Yock Young Dan 6, Lei Zhou 7, Glenn …

Targeting RNA Editing of Antizyme Inhibitor 1: a Potential Oligonucleotide-Based Antisense Therapy for Cancer (Mol Ther, May 2021) Read More »

Topography of Transcriptionally Active Chromatin in Glioblastoma (Sci Adv, Apr 2021)

Liang Xu 1 2, Ye Chen 1, Yulun Huang 3 4 5, Edwin Sandanaraj 6 7, John S Yu 8, Ruby Yu-Tong Lin 9, Pushkar Dakle 9, Xin-Yu Ke 9, Yuk Kien Chong 6, Lynnette Koh 6 10, Anand Mayakonda 9, Kassoum Nacro 11, Jeffrey Hill 12, Mo-Li Huang 9 13, Sigal Gery 14, See Wee Lim 6, Zhengyun Huang 15, Ying Xu 15, Jianxiang Chen 16 17 18, Longchuan Bai 19 20, Shaomeng Wang 19 20 21 22, Hiroaki Wakimoto 23, Tseng Tsai Yeo 24, Beng Ti …

Topography of Transcriptionally Active Chromatin in Glioblastoma (Sci Adv, Apr 2021) Read More »